Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.52−0.03 (-5.87%)
Close on Nov 12, 2026Market cap $48.56MP/E –Yield –
Citius Oncology operating margin
Operating margin is operating income as a percentage of revenue.
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -583.5% | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -1716.2% | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -133.2% | – |
See a number that looks wrong?